Markets › Stocks › CONCORD
CO

Concord Drugs Ltd

NSE: CONCORDBSE: 538965Healthcare
Download Research Report7-page PDF
₹81.95
▼ -0.41%
NSE · auto-updates while market open
Mkt Cap
₹106 Cr
P / E
99.8
P / B
2.2
ROE
2.6%
52W High
₹92.52
52W Low
₹29.00
Key Metrics
Market Cap
₹106 Cr
P / E
99.82
P / B
2.18
EV / EBITDA
27.03
ROCE
5.6%
ROE
2.6%
Debt / Equity
0.28
Book Value
₹36.82
EPS
₹0.95
Div Yield
0.0%
Face Value
-
Promoter Holding
54.4%
Revenue · ₹ Cr
51
FY20
51
FY21
59
FY22
52
FY23
45
FY24
45
FY25
79
FY26
Net Profit · ₹ Cr
0
FY20
3
FY21
2
FY22
1
FY23
0
FY24
0
FY25
1
FY26
EPS · ₹ per share
₹0.4
FY20
₹3.8
FY21
₹1.8
FY22
₹1.1
FY23
₹0.5
FY24
₹0.3
FY25
₹0.9
FY26
Q1 2026 snapshot
Sales
₹38 Cr
Operating profit
-
OPM
-
Net profit
₹1 Cr
EPS
₹0.47
Scorecard · 7 axes
Quality
Weak
37/100
Valuation
Bad
99.8×
Growth
Bad
-1.2%
Profitability
Bad
4.1%
Performance
Strong
+151.9%
Entry Point
Avg
89%
Red Flags
Strong
0 flags
Shareholding Pattern
54.4%Promoter
Promoter54.4%
Public45.6%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue10.810.413.6110.2816.9937.9
Net Profit0.2270.0390.1180.1920.2170.528
NPM %2.1%0.4%0.9%1.9%1.3%1.4%
AlertPre-trade